Once-daily aminoglycoside therapy: Potential ototoxicity (multiple letters)

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 4, 1997, Pages 879-880

  Kirkpatrick, Carl M J ^a   Duffull, Stephen B ^a   Begg, Evan J ^a  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

GENTAMICIN;

AREA UNDER THE CURVE; DOSE RESPONSE; DRUG CLEARANCE; DRUG MONITORING; HUMAN; LETTER; NOMOGRAM; OTOTOXICITY; PRIORITY JOURNAL;

EID: 0030950096     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.4.879     Document Type: Letter

References (5)

1. Barclay, M. L., and E. J. Begg. 1994. Aminoglycoside toxicity and relation to dose regimen. Adverse Drug React. Toxicol. Rev. 13:207-234.
2. Begg, E. J., M. L. Barclay, and S. B. Duffull. 1995. A suggested approach to once-daily aminoglycoside dosing. Br. J. Clin. Pharmacol. 39:605-609.
3. Begg, E. J., S. B. Duffull, and C. M. Kirkpatrick. 1996. Exposure to aminoglycosides should be monitored during treatment. Br. Med. J. 313:491.
4. Nicolau, D. P., C. D. Freeman, P. P. Belliveau, C. H. Nightingale, J. W. Ross, and R. Quintiliani. 1995. Experience with a once-daily aminoglycoside program administered to 2,184 adult patients. Antimicrob. Agents Chemother. 39:650-655.
5. Singer, C., C. Smith, and D. Krieff. 1996. Once-daily aminoglycoside therapy: potential ototoxicity. Antimicrob. Agents Chemother. 40:2209-2211.